Stay updated on Venetoclax and Novel Agents in AML Clinical Trial
Sign up to get notified when there's something new on the Venetoclax and Novel Agents in AML Clinical Trial page.

Latest updates to the Venetoclax and Novel Agents in AML Clinical Trial page
- Check3 days agoChange DetectedThe page has been updated to reflect a new version number, changing from v2.14.4 to v2.15.0, and the date has been updated from November 13, 2024, to April 11, 2025.SummaryDifference2%
- Check10 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.3%
- Check17 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check53 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
- Check68 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.SummaryDifference6%
- Check75 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.3%
- Check89 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.3%
Stay in the know with updates to Venetoclax and Novel Agents in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Venetoclax and Novel Agents in AML Clinical Trial page.